Interestingly, Sun et al. [16] analyzed IgM and IgG responses against SARS-CoV-2 nucleocapsid (N) and spike (S) protein after symptom onset depending on the severity of COVID-19. The gene discussed is CHMP5; the disease is COVID-19.